Search results
Results from the WOW.Com Content Network
This drug, like many others, normally requires large dosages to reach the target brain tissue diffusion from the blood, leading to systemic toxicity and the possibilities of multiple harmful side effects manifesting throughout the body. However, focused ultrasound has the potential to increase the safety and efficacy of drug delivery to the brain.
The overall drug consumption and side-effects may be lowered significantly by depositing the active pharmaceutical agent in the diseased region only and in no higher dose than needed. Targeted drug delivery is intended to reduce the side effects of drugs in tandem decreases in consumption and treatment expenses.
Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential ...
The advantages to the targeted release system is the reduction in the frequency of the dosages taken by the patient, having a more uniform effect of the drug, reduction of drug side-effects, and reduced fluctuation in circulating drug levels. The disadvantage of the system is high cost, which makes productivity more difficult, and the reduced ...
In special cases, nanotechnology can help reduce costs for complicated problems. But in most cases, the traditional method for construction remains more cost-efficient. [11] With the improvement of manufacturing technologies, the costs of applying nanotechnology into construction have been decreasing over time and are expected to decrease more ...
This list is not limited to drugs that were ever approved by the FDA. Some of them (lumiracoxib, rimonabant, tolrestat, ximelagatran and ximelidine, for example) were approved to be marketed in Europe but had not yet been approved for marketing in the US, when side effects became clear and their developers pulled them from the market.
For premium support please call: 800-290-4726 more ways to reach us
In 2016, the American Medical Association adopted a policy to discourage prescriptions of nootropics for healthy people, on the basis that the cognitive effects appear to be highly variable among individuals, are dose-dependent, and limited or modest at best. [16] Piracetam, noopept and meclofenoxate have been sold as dietary supplements. [2 ...